Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Filings indexed 288 across all filing types
Latest filing 2024-07-12 Director's Dealing
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. This type of filing is a standard regulatory disclosure for insider shareholding changes, which falls under the 'Director's Dealing' category in the provided schema.
2024-07-12 Korean
[기재정정]전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Kolon TissueGene regarding the exercise of conversion rights (converting convertible bonds into shares). It details the correction of a previously filed report due to administrative delays, specifically updating the listing date for the newly issued shares. This type of filing, which concerns the issuance of new shares resulting from the conversion of debt instruments, falls under the category of share issues or capital changes.
2024-07-09 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting, and mentions that materials will be posted on a specific date. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a regulatory filing announcement or general regulatory notice.
2024-07-08 Korean
증권발행결과(자율공시) (제2회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, the payment date, and the type of security. This falls under the category of capital and financing updates, specifically related to the issuance of new financial instruments.
2024-07-05 Korean
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Kolon TissueGene regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which falls under capital changes and share issuance. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital structure changes resulting from such conversions.
2024-06-28 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings Classification · 100% confidence The document is a short announcement from Kolon TissueGene regarding a change in its industry classification code due to a revision in the Korean Standard Industrial Classification. It is a regulatory notification issued to the market via the Korea Exchange. Since it does not fit into specific categories like financial reports, M&A, or dividends, and is a general regulatory announcement, it falls under the RNS category.
2024-06-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.